Detrol la and Urinary incontinence - a phase IV clinical study of FDA data
Summary:
Urinary incontinence is found among people who take Detrol la, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Detrol la and have Urinary incontinence. It is created by eHealthMe based on reports of 12,843 people who have side effects when taking Detrol la from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
12,843 people reported to have side effects when taking Detrol la.
Among them, 353 people (2.75%) have Urinary incontinence.
What is Detrol la?
Detrol la has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 13,128 Detrol la users for its effectiveness, alternative drugs and more.
What is Urinary incontinence?
Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 2,949 drugs and 2,331 conditions by eHealthMe.
Number of Detrol la and Urinary incontinence reports submitted per year:

Time on Detrol la when people have Urinary incontinence *:
Gender of people who have Urinary incontinence when taking Detrol la*:
Age of people who have Urinary incontinence when taking Detrol la *:
Common drugs people take besides Detrol la *:
Common side effects people have besides Urinary incontinence *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Detrol la and have Urinary incontinence?
Check whether Urinary incontinence is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Urinary incontinence and when was it recovered:
Expand to all the drugs that have ingredients of tolterodine tartrate:
Alternative drugs to, pros and cons of Detrol la:
- Detrol la (13,128 reports)
Common Detrol la side effects:
- Drug ineffective: 2,367 reports
- Constipation: 655 reports
- Dizziness: 553 reports
- Fatigue (feeling of tiredness): 552 reports
- Diarrhea: 489 reports
- Pain: 486 reports
Browse all side effects of Detrol la:
a b c d e f g h i j k l m n o p q r s t u v w x y zUrinary incontinence treatments and more:
- Urinary incontinence (45,206 reports)
COVID vaccines that are related to Urinary incontinence:
- Urinary incontinence in Moderna COVID Vaccine
- Urinary incontinence in Pfizer BioNTech Covid Vaccine
- Urinary incontinence in Johnson and Johnson Covid Vaccine
Common drugs associated with Urinary incontinence:
- Aspirin: 1,912 reports
- Prednisone: 1,393 reports
- Avonex: 1,319 reports
- Omeprazole: 1,287 reports
- Fosamax: 1,217 reports
- Gabapentin: 1,180 reports
- Tysabri: 1,163 reports
- Metformin: 1,140 reports
- Lisinopril: 1,108 reports
- Detrol: 1,016 reports
All the drugs that are associated with Urinary incontinence:
- Urinary incontinence (2,949 drugs)
Common conditions associated with Urinary incontinence:
- Multiple sclerosis: 4,660 reports
- High blood pressure: 1,790 reports
- Pain: 1,415 reports
- Depression: 1,376 reports
- Osteoporosis: 1,369 reports
- Rheumatoid arthritis: 1,068 reports
All the conditions that are associated with Urinary incontinence:
- Urinary incontinence (2,331 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tolterodine tartrate (the active ingredients of Detrol la) and Detrol la (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Linagliptin and Liver Function Test Abnormal - 3 seconds ago
- How effective is Cymbalta for Sleep Disorder? - 3 seconds ago
- Cyclophosphamide and Cefoxitin drug interaction - 5 seconds ago
- Norvasc and Metformin Hydrochloride drug interaction - 8 seconds ago
- Anoro Ellipta and Travoprost drug interaction - 10 seconds ago
- Temporal Lobe Epilepsy and Hypotension - 12 seconds ago
- Loryna and Sprintec drug interaction - 18 seconds ago
- Cefuroxime and Bone Loss - 18 seconds ago
- Metformin Hydrochloride vs. Glucotrol Xl - 21 seconds ago
- Combivent Respimat and Eszopiclone drug interaction - 21 seconds ago